LogoCrystal's MCW Coder Hub

51585

31 min read

CPT 51585 — Cystectomy, Complete, with Bilateral Pelvic Lymphadenectomy and Ureteroileal Conduit or Sigmoid Bladder

Overview and Clinical Description

CPT 51585 is the most comprehensive of the cystectomy codes that includes a non-continent urinary diversion performed in a single operative session. It combines three major surgical components: (1) complete removal of the urinary bladder, (2) bilateral pelvic lymphadenectomy encompassing the external iliac, hypogastric (internal iliac), and obturator lymph node chains, and (3) creation of a ureteroileal conduit (Bricker conduit) or a sigmoid bladder as the urinary diversion, including the requisite intestinal anastomosis to restore bowel continuity. The fact that all three components are bundled into a single code reflects the reality that, at most high-volume centers, these operations are performed together as a single-session procedure in appropriately selected patients.

The Bricker ileal conduit — by far the most commonly employed non-continent diversion — uses an isolated 15-20 cm segment of distal ileum as a passive conduit: the ureters are anastomosed to the proximal end of the isolated segment and the distal end is brought out to the skin of the right lower quadrant as an incontinent stoma, from which urine drains continuously into an external pouching appliance. There is no internal reservoir, no valve mechanism, and no requirement for patient catheterization. This simplicity makes the ileal conduit the most reliable and durable urinary diversion available, particularly for elderly patients, patients with significant comorbidities, or those who cannot participate in the self-management required by continent diversions.

The sigmoid bladder (also called a sigmoid conduit or ureterosigmoidostomy-variant diversion) uses a segment of sigmoid colon rather than ileum as the conduit. This approach is less common in modern practice but remains appropriate in select cases where the ileum has been damaged by prior radiation therapy, surgical resection, or Crohn’s disease. The sigmoid segment is used in the same passive conduit configuration as the ileal segment in a Bricker procedure.

Understanding 51585 in context requires appreciating what distinguishes it from neighboring codes in the cystectomy family. Compared to 51580 (cystectomy with lymphadenectomy but without diversion), 51585 adds the ileal conduit or sigmoid bladder component, which is itself a major bowel procedure. Compared to 51590 (cystectomy with ureteroileal conduit but without lymphadenectomy named in the descriptor), 51585 explicitly includes the bilateral pelvic lymphadenectomy. The wRVU value of 51585 is correspondingly higher than either of those codes individually, reflecting the triple-component operative complexity.

Anatomy and Surgical Context

The operative anatomy of 51585 encompasses three distinct anatomical territories that must all be navigated in a single prolonged surgical session: the bladder and its pelvic attachments, the bilateral pelvic lymphatic basins, and the distal small intestine or sigmoid colon used for conduit construction.

The bladder dissection and removal follows the same principles described in 51570 and 51580 — division of the lateral vascular pedicles containing the superior and inferior vesical vessels, anterior division of the puboprostatic (males) or pubovesical (females) ligaments with control of the dorsal venous complex, and posterior dissection through the Denonvilliers fascia plane (males) or the vesicovaginal plane (females). In males, the prostate and seminal vesicles are typically removed en bloc with the bladder; in females, the anterior vaginal wall and often the uterus, fallopian tubes, and ovaries are resected together with the bladder.

The bilateral pelvic lymphadenectomy encompasses the same three nodal chains named in 51580. The obturator fossa dissection — clearing the obturator lymph nodes from around the obturator nerve and vessels — is the most technically demanding component, requiring complete nerve identification and preservation to prevent post-operative adductor weakness. The external iliac chain is cleared from the bifurcation of the common iliac artery down to the circumflex iliac vein. The hypogastric chain follows the branches of the internal iliac artery into the deep pelvis. Each nodal packet is labeled and submitted separately for pathologic staging. Extended templates additionally clear the common iliac and pre-sacral nodes; the standard three-chain template named in 51585 remains the most widely practiced.

The conduit construction begins with isolation of the ileal segment approximately 15-20 cm proximal to the ileocecal valve (to protect terminal ileal vitamin B12 absorption), maintaining the mesenteric vascular pedicle intact. A 15-20 cm segment is selected, the ileum is divided at both ends using staplers or bowel clamps, and bowel continuity is restored proximal to the isolated segment with a hand-sewn or stapled anastomosis. The isolated conduit segment is then oriented isoperistaltically (proximal end toward the ureters, distal end toward the skin). The left ureter is typically brought under the sigmoid mesentery retroperitoneally to reach the left side of the conduit. Both ureters are spatulated and anastomosed to the proximal end of the conduit using the Wallace (conjoined) or Bricker (separate) technique with absorbable sutures. The distal end of the conduit is brought through a pre-marked trephine in the right lower quadrant abdominal wall and matured as a budded stoma protruding 2-3 cm above skin level. Internal ureteral stents are placed across the ureteroileal anastomoses and secured externally through the stoma, remaining in place for 7-10 days post-operatively to splint the healing anastomoses.

The entire operation typically takes 5-8 hours in an uncomplicated case and may extend considerably longer in post-radiation fields, obese patients, or those with prior pelvic surgery.

CPT Coding Details

Work RVU (wRVU): Approximately 57.79 (verify against the current-year CMS Physician Fee Schedule; RVU values are updated annually and may differ between facility and non-facility settings. This is one of the highest wRVU procedures in the urology CPT code set, reflecting the extraordinary scope and duration of the combined cystectomy, lymphadenectomy, and conduit construction.)

To put this in perspective, the wRVU for 51585 is roughly equivalent to the sum of its components: the cystectomy-with-PLND component (~36 wRVU for 51580) plus the bowel surgery and conduit construction component that would be required to build the diversion independently. The bundled nature of 51585 as a single combined code ensures appropriate valuation for an operation that routinely occupies an entire operative day.

Global Period: 90 days. All routine post-operative management by the operating surgeon is included in the global surgical fee for 90 days from the date of service.

Assistant Surgeon: Yes — payable. 51585 is among the procedures for which an assistant surgeon is not only appropriate but essentially required for safe performance. The simultaneous pelvic dissection and bowel reconstruction, the depth and narrowness of the pelvic operative field, the need for continuous tissue retraction during bilateral lymphadenectomy, and the precision required for the ureteroileal anastomoses all mandate continuous skilled assistance. Modifier -80 (Assistant Surgeon) or -82 (when a qualified resident is unavailable) is applied to the assistant’s claim. The operative report should document the assistant’s active and substantive contribution throughout the procedure, particularly during the lymphadenectomy and conduit construction phases.

Bilateral Indicator: 0 — the bilateral nature of the lymphadenectomy is inherent in the 51585 descriptor. No bilateral modifier is applicable.

Multiple Procedure Indicator: 2 — standard 50% multiple procedure reduction applies to the lower-valued procedure when 51585 is billed alongside other separately reportable procedures at the same operative session.

Modifier Applicability:

  • -22 (Increased Procedural Services) — Warranted when the operative complexity substantially exceeds the expected baseline for 51585, such as in patients with prior pelvic radiation creating dense tissue fibrosis, extensive prior pelvic surgery with adhesions, morbid obesity with challenging conduit delivery through the abdominal wall, bilateral bulky nodal disease requiring extended dissection, or significant intraoperative complications such as rectal injury requiring formal repair. The operative note must explicitly describe the complicating factors, quantify additional time and work, and explain why the service was significantly beyond the standard procedure. A separate operative report addendum or letter of medical necessity may be required by the payer.
  • -51 (Multiple Procedures) — Applied to the lower-valued additional procedure when 51585 is billed concurrently with other distinct separately payable services on the same date.
  • -62 (Two Surgeons) — Applicable when two surgeons with distinct expertise each perform clearly identifiable separate components simultaneously — for example, a urologist performing the cystectomy and lymphadenectomy while a colorectal surgeon simultaneously manages the bowel resection and conduit construction.
  • -78 (Unplanned Return to OR, Related Procedure) — For return to the operating room during the 90-day global period due to directly related complications such as ureteroileal anastomotic leak, conduit ischemia requiring stomal revision, pelvic hematoma, lymphocele requiring drainage, or bowel anastomotic disruption.
  • -80 / -82 — For assistant surgeon claims as described above.

Associated ICD-10-CM Diagnoses

The following diagnoses represent the most clinically important indications and co-existing conditions for CPT 51585. Because 51585 includes a bilateral pelvic lymphadenectomy, it is an almost exclusively oncologic procedure — the PLND component serves no purpose in benign disease. HCC assignments reflect the CMS HCC Risk Adjustment Model v24 and v28 where applicable. For inpatient facility billing, CC/MCC designation is the primary driver of MS-DRG tier assignment and is identified for each code.

C67.0 — Malignant Neoplasm of Trigone of Bladder

Trigonal location places the primary tumor at the base of the bladder, in close proximity to both ureteric orifices and the bladder neck. Muscle-invasive disease at the trigone is among the strongest indications for radical cystectomy because the tumor’s location makes transurethral resection insufficient for local control. Frozen section of the ureteral margins is standard when the tumor involves or closely approaches the ureteric orifices, as a positive distal ureteral margin necessitates additional resection. Site specificity should always be obtained from the TURBT pathology report, pre-operative cystoscopy documentation, and imaging rather than defaulting to the unspecified code.

HCC v24: HCC 11 — Colorectal, Bladder, and Other Cancers HCC v28: HCC 17 — Lung and Other Severe Cancers CC/MCC (Inpatient): MCC

C67.1 — Malignant Neoplasm of Dome of Bladder

Dome tumors may arise from the urachal remnant, raising the possibility of urachal carcinoma — a histologically distinct adenocarcinoma variant with a worse prognosis than conventional urothelial carcinoma. When the dome tumor is pathologically confirmed as urachal adenocarcinoma, C67.7 is the more specific code. Standard transitional cell / urothelial dome carcinoma with muscle invasion is captured here.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.2 — Malignant Neoplasm of Lateral Wall of Bladder

Lateral wall location is the single most common anatomical site for urothelial bladder carcinoma. The obturator lymph nodes are the first-echelon basin for lateral wall primaries, making the obturator fossa dissection component of 51585 especially important for accurate staging of these tumors. Any documented obturator or external iliac nodal involvement should prompt assignment of C77.5 as an additional diagnosis.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.3 — Malignant Neoplasm of Anterior Wall of Bladder

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.4 — Malignant Neoplasm of Posterior Wall of Bladder

Posterior wall tumors with extravesical extension (T3b) directly abut the rectum in males (separated by Denonvilliers fascia) and the vagina in females. When the operative report documents direct tumor invasion into the rectum or vagina, the extent of the resection may qualify as a pelvic exenteration (51597) rather than 51585, and the principal diagnosis should reflect the full extent of disease including any involved adjacent organ.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.5 — Malignant Neoplasm of Bladder Neck

Bladder neck involvement raises operative planning complexity, particularly regarding urethral margin assessment. In males, a positive urethral frozen section intraoperatively indicates the need for concurrent urethrectomy to achieve clear margins. The non-continent ileal conduit selected in 51585 already bypasses the urethra entirely, so post-operative voiding considerations do not influence diversion selection as they do in neobladder candidates.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.6 — Malignant Neoplasm of Ureteric Orifice

Proximity to the ureteric orifice mandates careful intraoperative frozen section assessment of both distal ureteral margins. When one or both ureteral margins are involved by tumor, additional ureteral resection is required before the conduit anastomosis can proceed with confidence in the oncologic completeness of the resection.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.7 — Malignant Neoplasm of Urachus

Urachal carcinoma is a rare, biologically aggressive adenocarcinoma arising from the vestigial urachal remnant extending from the bladder dome to the umbilicus. Standard management includes en bloc resection of the bladder dome, urachal tract to or including the umbilicus, and regional lymphadenectomy. The ileal conduit is frequently the diversion of choice given the complexity of the resection and the typical patient population.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.8 — Malignant Neoplasm of Overlapping Sites of Bladder

Used when the primary tumor involves two or more contiguous bladder sites without a clearly identifiable dominant site of origin. This code is most applicable to large, multifocal, or deeply invasive tumors at the time of cystectomy when the TURBT and imaging documentation describes disease throughout multiple bladder walls.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C67.9 — Malignant Neoplasm of Bladder, Unspecified

Reserved for cases where site-specific documentation is genuinely absent from the operative report, cystoscopy, TURBT pathology, and imaging. This should be considered a code of last resort — always query for site specificity from all available records before assigning C67.9.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

C77.5 — Secondary and Unspecified Malignant Neoplasm of Intrapelvic Lymph Nodes

This secondary diagnosis code is one of the most consequential and most commonly missed in 51585 coding. When final surgical pathology returns confirming metastatic urothelial carcinoma in any of the resected pelvic lymph node packets — obturator, external iliac, or hypogastric — C77.5 must be assigned as an additional diagnosis. Node-positive disease (pN1-pN3 in the TNM staging system) represents pathologic upstaging from the clinical stage at the time of surgery and directly influences adjuvant chemotherapy decisions, prognosis counseling, and oncologic follow-up planning.

From a coding standpoint, C77.5 carries both MCC designation at the inpatient level and HCC 11 value in the risk adjustment context, layering additional complexity on top of the primary C67.x MCC. When both codes are assigned, the record carries two independent MCC-bearing diagnoses, which accurately reflects the clinical severity of node-positive muscle-invasive bladder cancer. This code should not be pre-assigned speculatively — it should only be coded when final pathology confirms nodal metastases.

HCC v24: HCC 11 HCC v28: HCC 17 CC/MCC (Inpatient): MCC

D09.0 — Carcinoma In Situ of Bladder

BCG-unresponsive or BCG-refractory high-grade carcinoma in situ (CIS, stage Tis) is a well-established indication for radical cystectomy even in the absence of frank muscle invasion, given the high rate of progression to invasive disease when intravesical therapy has failed. An ileal conduit is frequently chosen for CIS patients undergoing cystectomy because they often tend to be older or have contraindications to the continence mechanisms required for neobladder use. D09.0 carries CC designation — not MCC — at the inpatient level, which is lower than invasive C67.x codes. This distinction matters significantly for DRG tier assignment.

HCC v24: HCC 11 — CIS of bladder maps to HCC 11 in v24, a point frequently missed by coders who assume only invasive malignancy carries HCC weight. HCC v28: HCC 17 CC/MCC (Inpatient): CC

D62 — Acute Posthemorrhagic Anemia

Significant intraoperative blood loss is one of the most predictable complications of 51585, given the vascularity of the pelvic dissection, the necessity of controlling the dorsal venous complex, and the potential for injury to the iliac vessels during lymphadenectomy. When post-operative hemoglobin values are low and the physician documents acute blood loss anemia — or when transfusion of packed red blood cells is required and the clinical picture supports it — D62 should be assigned. It carries CC designation and contributes to DRG tier optimization.

HCC v24: Not assigned (anemia code; no HCC value) HCC v28: Not assigned CC/MCC (Inpatient): CC

E43 — Unspecified Severe Protein-Calorie Malnutrition

Neoadjuvant platinum-based chemotherapy (gemcitabine/cisplatin or dose-dense MVAC) is the standard of care preceding radical cystectomy for muscle-invasive bladder cancer and routinely causes nausea, vomiting, anorexia, mucositis, and significant weight loss over the 8-12 weeks of treatment. Patients presenting for 51585 frequently have pre-operative albumin levels below 3.0 g/dL and documented weight loss exceeding 10% of baseline body weight. When the attending physician documents malnutrition — whether at admission, in the pre-operative assessment, or during the inpatient stay — severe protein-calorie malnutrition (E43) carries MCC designation and moderate protein-calorie malnutrition (E44.0) carries CC designation. These are among the most impactful undercoded diagnoses in the cystectomy population. A targeted physician query is entirely appropriate when lab values and clinical context support it.

HCC v24: Not assigned HCC v28: Not assigned CC/MCC (Inpatient): MCC

E44.0 — Moderate Protein-Calorie Malnutrition

When malnutrition is documented at a moderate level — albumin 2.5-3.5 g/dL, documented weight loss 5-10%, dietitian consultation noting moderate nutritional deficit — E44.0 applies. It carries CC designation at the inpatient level.

HCC v24: Not assigned HCC v28: Not assigned CC/MCC (Inpatient): CC

ICD-10-PCS Inpatient Equivalents

In the inpatient facility setting, CPT 51585 has no role — ICD-10-PCS codes drive MS-DRG assignment exclusively. The procedure encompasses at minimum four distinct root operations that must each be separately captured: cystectomy (Resection), lymphadenectomy (Excision), ureteral bypass to the conduit (Bypass), bowel excision for conduit harvest (Excision), and bowel re-anastomosis (Repair). Failure to assign all applicable procedure codes significantly underrepresents the operative complexity in the abstraction and can result in lower-weighted DRG assignment.

Root Operation: Resection — Bladder Complete removal of the bladder is encoded as Resection (T), body part Bladder (B), Open approach (0), no device, no qualifier.

0TTB0ZZ — Resection of Bladder, Open Approach

This is the principal ICD-10-PCS procedure code for the cystectomy component and is always present in a complete cystectomy. For robotic or laparoscopic approaches, the approach character changes to 4 (Percutaneous Endoscopic).

Root Operation: Excision — Lymphatics, Pelvis Bilateral pelvic lymphadenectomy is encoded as Excision (B), body part Pelvic Lymphatic (9), Open approach (0), no qualifier.

07B90ZZ — Excision of Pelvic Lymphatic, Open Approach

Consult AHA Coding Clinic guidance regarding laterality coding for bilateral simultaneous lymphadenectomy — some facilities assign a single bilateral pelvic lymphatic code while others assign right and left separately.

Root Operation: Bypass — Ureter to Ileum (Conduit Anastomosis) The ureteroileal anastomosis — diverting urine from the ureters into the conduit — is encoded as Bypass (1), Urinary System table (0T1), body part Right Ureter (7) and Left Ureter (8), Open approach (0), qualifier Ileum (B).

0T170ZB — Bypass Right Ureter to Ileum, Open Approach 0T180ZB — Bypass Left Ureter to Ileum, Open Approach

Both right and left bypass codes are typically assigned when a bilateral ureteroileal conduit anastomosis is performed.

Root Operation: Excision — Small Intestine (Conduit Harvest) The isolation and harvest of the ileal conduit segment is encoded as Excision (B), Gastrointestinal System (0D), body part Small Intestine (8), Open approach (0).

0DB80ZZ — Excision of Small Intestine, Open Approach

Root Operation: Repair — Small Intestine (Bowel Re-anastomosis) Restoration of bowel continuity after conduit harvest is encoded as Repair (Q), body part Small Intestine (8), Open approach (0).

0DQ80ZZ — Repair Small Intestine, Open Approach

Additional Codes When Applicable in Males:

For concurrent resection of the prostate and seminal vesicles (when performed en bloc): 0VT00ZZ — Resection of Prostate, Open Approach 0VT30ZZ — Resection of Bilateral Seminal Vesicles, Open Approach

Coder Note: The single most common ICD-10-PCS error for 51585 cases is incomplete procedure code assignment. Abstractors often capture the bladder resection (0TTB0ZZ) and miss one or more of the lymphadenectomy, ureteral bypass, bowel excision, and bowel repair codes. All five to seven procedure codes must be present in the final abstraction to fully represent the operative complexity. Run a procedure completeness check by comparing your assigned codes against each discrete component described in the operative report before submission.

MS-DRG Assignment

ICD-10-PCS codes assigned for 51585 map through MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract as a major bladder procedure. The DRG tier depends on the principal diagnosis and the presence of MCCs and CCs across all coded diagnoses.

MS-DRGDescriptionRelative Weight (approx.)
660Major Bladder Procedures with MCC~4.7-5.2
661Major Bladder Procedures with CC~2.9-3.3
662Major Bladder Procedures without CC/MCC~2.0-2.4

When the principal diagnosis is an active bladder malignancy, the case may alternatively sort into the kidney and ureter neoplasm DRGs depending on the grouper logic applied to the specific PCS procedure code combination:

MS-DRGDescriptionRelative Weight (approx.)
656Kidney and Ureter Procedures for Neoplasm with MCC~4.0-4.6
657Kidney and Ureter Procedures for Neoplasm with CC~2.4-2.8
658Kidney and Ureter Procedures for Neoplasm without CC/MCC~1.7-2.0

Inpatient Coder Tip — DRG Strategy for 51585 Cases: Because virtually every 51585 case is performed for active bladder malignancy — and C67.x codes carry MCC designation — the overwhelming majority of 51585 cases will group to DRG 660 or 656, the highest-weighted tiers, as long as the active malignancy code is correctly assigned. The critical risk is the unintentional substitution of Z85.51 (personal history, no CC/MCC) for the active malignancy C67.x code (MCC), which drops the case from DRG 660 to DRG 661 or 662 and represents a substantial reimbursement loss. Additionally, always check final pathology before abstracting: if lymph nodes are positive, C77.5 (MCC, HCC 11) must be added. If the patient had neoadjuvant chemotherapy and presents with documented malnutrition, E43 (MCC) can provide a second independent MCC that reinforces the DRG 660 placement even in cases where the malignancy code alone was sufficient. Post-operative complications routinely encountered in 51585 patients — acute blood loss anemia D62 (CC), ileus K56.7 (CC), deep vein thrombosis I82.4x1 (CC), post-operative infection T81.40XA (CC), and sepsis A41.x (MCC) — should all be coded when documented, as each contributes to the clinical complexity picture and may influence DRG assignment in borderline CC/MCC scenarios.

Code Tree — Related CPT Codes

Understanding the precise position of 51585 in the cystectomy code family is one of the most important skill-building exercises for urologic inpatient coders. The code series has a logical architecture — each code represents a specific combination of operative components — and selecting the wrong code invariably leads to either under-reporting or over-reporting of the procedure.

Partial Cystectomy (Bladder Preservation):

  • 51550 — Cystectomy, partial, simple.
  • 51555 — Cystectomy, partial, complicated.
  • 51565 — Cystectomy, partial, with ureteral reimplantation.

Complete Cystectomy Without Lymphadenectomy or Diversion:

  • 51570 — Cystectomy, complete (separate procedure). The simplest standalone complete cystectomy — no PLND, no diversion.

Complete Cystectomy with Lymphadenectomy, No Diversion:

  • 51575 — Cystectomy, complete, with bilateral pelvic lymphadenectomy (external iliac, hypogastric, obturator). No diversion. (See note on 51575 vs. 51580 distinction in the 51580 reference note.)
  • 51580 — Cystectomy, complete, with bilateral pelvic lymphadenectomy. No diversion.

Complete Cystectomy with Non-Continent Diversion, Without Named Lymphadenectomy:

  • 51590 — Cystectomy, complete, with ureteroileal conduit or sigmoid bladder, including intestinal anastomosis. PLND not named in descriptor; used when cystectomy and non-continent diversion are performed but the lymphadenectomy component is not the defining feature of the code selection.

Complete Cystectomy with Lymphadenectomy and Non-Continent Diversion:

  • 51585 — This code. Cystectomy, complete, with bilateral pelvic lymphadenectomy (external iliac, hypogastric, obturator) AND ureteroileal conduit or sigmoid bladder, including intestinal anastomosis. The full triple-component open procedure.

Complete Cystectomy with Continent Diversion (Neobladder):

  • 51595 — Cystectomy, complete, with continent diversion using intestinal segment (neobladder), open. No prostatectomy named.
  • 51596 — Cystectomy, complete, with continent diversion and radical prostatectomy. Male patients where formal radical prostatectomy technique is employed.

Pelvic Exenteration:

  • 51597 — Pelvic exenteration, complete, for vesical, prostatic, or urethral malignancy. The most extensive pelvic oncologic resection, including bladder, rectum, and involved adjacent organs.

Standalone Diversion After Prior Cystectomy:

  • 50825 — Continent diversion/neobladder construction, open (staged after prior cystectomy).
  • 50830 — Urinary undiversion with intestinal segment reimplantation.

Urethrectomy (Concurrent):

  • 53210 — Urethrectomy, total, including cystostomy, male.
  • 53215 — Urethrectomy, total, female.

Critical Note — 51585 vs. 51590: The operative distinction between 51585 and 51590 is the explicit bilateral pelvic lymphadenectomy named in the 51585 descriptor. If the operative report documents a complete cystectomy with ileal conduit creation but does NOT include a pelvic lymphadenectomy, 51590 is the correct code. If the bilateral PLND is performed and documented as a component of the same operative session, 51585 is the correct code. The wRVU difference between 51590 (~42.68) and 51585 (~57.79) is significant, making correct code selection an important reimbursement accuracy issue. Always confirm from the operative report whether a PLND was performed and, if so, which nodal stations were dissected.

Includes

The following services are included within CPT 51585 and must not be separately billed when performed as integral components of the procedure:

From the cystectomy component:

  • Complete bladder mobilization and dissection — division of lateral vascular pedicles, anterior ligament division with dorsal venous complex control, posterior plane dissection (Denonvilliers fascia in males, vesicovaginal plane in females).
  • En bloc resection of the bladder with perivesical fat, peritoneal reflections, seminal vesicles (males), and relevant portions of the prostate or vaginal wall as integral to the dissection.
  • Division, ligation, and temporary management of both ureters.

From the lymphadenectomy component:

  • Systematic bilateral pelvic lymph node dissection of the external iliac, hypogastric, and obturator chains.
  • Identification and preservation of the bilateral obturator nerves.
  • Hemostatic ligation of lymphatic channels.
  • Submission of separately labeled nodal packets for pathologic staging.
  • Intraoperative frozen section of lymph node specimens performed for immediate surgical decision-making.

From the conduit construction component:

  • Isolation and harvest of the ileal conduit segment with its mesenteric pedicle.
  • Bowel re-anastomosis to restore intestinal continuity.
  • Bilateral ureteroileal anastomosis (Wallace or Bricker technique) with placement of internal stents across the anastomoses.
  • Conduit delivery through the abdominal wall trephine and stomal maturation.
  • Ostomy appliance placement at the time of wound closure.

General:

  • Intraoperative cystoscopy or fluoroscopy performed for guidance during the same operative session.
  • Pelvic drain placement as part of operative closure.

Excludes / Separate Billing Considerations

The following services are not included in 51585 and may be separately reportable under appropriate circumstances:

  • Extended lymphadenectomy beyond the standard template — When the lymphadenectomy is extended to common iliac, pre-sacral, or para-aortic nodes beyond the three chains named in the 51585 descriptor, the additional work is not captured by a separate code. Modifier -22 with detailed documentation is the mechanism for capturing substantially increased work related to extended nodal dissection.
  • Urethrectomy (53210, 53215) — Not included in 51585. When the urethra is removed as a separately planned component, it is separately reportable with modifier -51. The operative note must document the urethrectomy as a distinct operative step.
  • Concurrent oophorectomy, hysterectomy, or anterior vaginal wall resection in females — When these are performed as distinct oncologic components beyond what is inherent to the standard bladder dissection, appropriate gynecologic codes may be separately reportable with modifier -51. NCCI bundling edits should be reviewed.
  • Rectal repair for intraoperative injury — Separately reportable with modifier -51 if a rectal enterotomy occurs during the posterior dissection and requires formal repair.
  • Conduit revision during the global period — If the stoma requires revision during the 90-day global period due to stomal retraction, ischemia, or stenosis, modifier -78 applies for unplanned related returns to the operating room.
  • Ureteral stent removal after the global period — Stent removal by the operating surgeon within the 90-day global period is bundled. After the global period, stent removal is separately reportable.
  • Stomal appliance instruction and ostomy nursing visits — These are nursing and ancillary services, not separately reportable surgical procedures by the physician.

NCCI Bundling Alert: Do not report a standalone bilateral pelvic lymphadenectomy code (38770) separately alongside 51585. The PLND is intrinsic to the 51585 descriptor and is not separately payable. Similarly, do not report an ileal conduit creation code independently when 51585 captures the conduit as an integrated component of the combined procedure. Unbundling these components creates significant audit risk under NCCI edits and payer-specific bundling logic.

Coding Examples

Example 1 — Standard Radical Cystectomy, PLND, Bricker Ileal Conduit

A 69-year-old male with T2b high-grade urothelial carcinoma of the lateral wall of the bladder has completed 4 cycles of neoadjuvant gemcitabine/cisplatin chemotherapy. He is medically cleared for surgery and elects an ileal conduit diversion. He undergoes open radical cystoprostatectomy with bilateral pelvic lymphadenectomy (standard template: external iliac, hypogastric, obturator) and Bricker ileal conduit creation. The surgeon uses the Wallace technique for the bilateral ureteroileal anastomosis. Bowel continuity is restored with a stapled functional end-to-end anastomosis. Bilateral ureteral stents are placed. Final pathology: pT2aN0 (16 lymph nodes, all negative). Estimated blood loss 900 mL; 1 unit PRBC transfused intraoperatively.

Principal ICD-10-CM: C67.2 (Malignant neoplasm of lateral wall of bladder) Additional ICD-10-CM: D62 (Acute blood loss anemia — CC) CPT: 51585 MS-DRG: 660 (Major Bladder Procedures with MCC) — C67.2 is MCC, driving the highest DRG tier. D62 layering adds CC complexity within an already MCC-tier case. HCC: C67.2 → HCC 11 (v24); HCC 17 (v28). Full HCC value on all qualifying encounters going forward. Note: With a pathologic stage of pT2aN0 and negative nodes, C77.5 is not assigned. If nodes had been positive, C77.5 would be added as an additional MCC-bearing diagnosis.

Example 2 — Node-Positive Disease with Dual MCC Documentation

A 64-year-old female with T3a urothelial carcinoma of the posterior wall of the bladder undergoes open anterior pelvic exenteration with bilateral pelvic lymphadenectomy (external iliac, hypogastric, obturator) and Bricker ileal conduit. The uterus and bilateral adnexa are removed en bloc with the bladder given posterior wall extravesical extension. Final pathology confirms pT3aN2M0 — 3 of 22 pelvic lymph nodes positive for metastatic urothelial carcinoma (2 right obturator, 1 left external iliac). The patient’s pre-admission albumin is 2.4 g/dL; the attending documents moderate protein-calorie malnutrition in the admission H&P.

Principal ICD-10-CM: C67.4 (Malignant neoplasm of posterior wall of bladder) Additional ICD-10-CM: C77.5 (Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes — MCC — confirmed on final pathology), E44.0 (Moderate protein-calorie malnutrition — CC — albumin 2.4 g/dL, documented by attending), D62 (Acute blood loss anemia — CC — if post-operative hemoglobin drop with transfusion documented) CPT: 51585 MS-DRG: 660 (Major Bladder Procedures with MCC) — two independent MCC-level codes (C67.4 and C77.5) drive the maximum-weighted DRG tier. Additional CCs further reinforce the complexity of this record. HCC: C67.4 → HCC 11 (v24); C77.5 → HCC 11 (v24). Both carry independent HCC value for risk adjustment purposes. C77.5 is the code most often missed in the node-positive cystectomy scenario. Coding Note for Female Anterior Exenteration: The concurrent hysterectomy and bilateral salpingo-oophorectomy performed en bloc with the bladder for posterior wall extravesical extension are typically bundled within the cystectomy procedure when performed for the same oncologic indication. Do not separately report gynecologic resection codes unless payer-specific guidance or a distinct operative indication supports separate billing.

Example 3 — BCG-Refractory CIS, Cystectomy, PLND, Ileal Conduit, Older Patient

A 78-year-old male with BCG-unresponsive high-grade carcinoma in situ confirmed on two mapping biopsy sessions elects to proceed with cystectomy after shared decision-making. Due to his age, reduced functional reserve, and patient preference regarding appliance management over neobladder catheterization, the surgeon recommends an ileal conduit. He undergoes open cystoprostatectomy with bilateral pelvic lymphadenectomy and Bricker ileal conduit. All 18 lymph nodes are negative. Post-operative course: 4-day ileus with nasogastric decompression; post-operative day 6 hemoglobin 8.2 g/dL with physician-documented acute blood loss anemia.

Principal ICD-10-CM: D09.0 (Carcinoma in situ of bladder) Additional ICD-10-CM: K56.7 (Ileus, unspecified — CC), D62 (Acute blood loss anemia — CC) CPT: 51585 MS-DRG: 661 (Major Bladder Procedures with CC) — D09.0 is CC-level, not MCC. Without an independent MCC in the record, the case groups to DRG 661. This illustrates a key strategic coding point: CIS patients lack the automatic MCC that invasive C67.x cases provide. Thorough documentation of comorbidities — particularly severe malnutrition E43 (MCC) if applicable — is the pathway to DRG 660 in CIS cases if the clinical evidence supports it. Query the attending regarding nutritional status documentation. HCC: D09.0 → HCC 11 (v24); HCC 17 (v28). CIS of bladder carries full HCC value — do not overlook this in the risk adjustment context.

Example 4 — Sigmoid Bladder Variant, Prior Radiation, Modifier -22

A 71-year-old male with T2b bladder carcinoma and a history of pelvic radiation for rectal cancer 8 years prior undergoes open cystoprostatectomy with bilateral pelvic lymphadenectomy. Because the terminal ileum and distal small bowel show radiation-induced changes on pre-operative imaging, the surgeon elects to use a sigmoid conduit instead of an ileal conduit. The operative report documents 7 hours 15 minutes of operating time, dense radiation fibrosis throughout the pelvis requiring extensive sharp adhesiolysis, and significantly more complex ureteroileal anastomosis due to shortened and irradiated ureters. Final pathology: pT3bN0 (14 lymph nodes negative).

Principal ICD-10-CM: C67.9 (Malignant neoplasm of bladder, unspecified — query attending for site if not documented in available records) Additional ICD-10-CM: D62 (Acute blood loss anemia — CC — estimated blood loss 1,600 mL, 2 units PRBC) CPT: 51585-22 (Increased Procedural Services) Modifier -22 Supporting Documentation Must Include: Radiation fibrosis in operative field, use of sigmoid rather than ileal conduit due to radiation bowel damage, total operative time 7+ hours, estimated blood loss, specific description of the additional complexity encountered. MS-DRG: 660 (Major Bladder Procedures with MCC) — C67.9 is MCC. HCC: C67.9 → HCC 11 (v24); HCC 17 (v28). Query for site specificity — even a minimal response from the attending physician identifying the primary tumor location will allow substitution of a site-specific C67.x code for the unspecified C67.9.

Common Coder Pitfalls and Tips

1. 51585 vs. 51590 — The Lymphadenectomy Is the Differentiator. The single most important code selection distinction in this tier of the cystectomy family is whether a bilateral pelvic lymphadenectomy was performed and documented. If no PLND is documented, 51590 is the correct code. If PLND is documented, 51585 applies. Because 51585 carries a higher wRVU (~57.79) than 51590 (~42.68), failure to identify the PLND in the operative report and code it correctly results in significant under-reporting. Always scan the operative report’s procedure list, the body of the operative note, and the pathology requisitions (where separately labeled lymph node packets will appear) to confirm whether a PLND was performed.

2. Never Miss C77.5 When Nodes Are Positive. Final surgical pathology confirming pelvic lymph node metastases mandates assignment of C77.5 as an additional diagnosis. It carries independent MCC designation and HCC 11 value. It is the single most impactful diagnosis code that is routinely missed in cystectomy abstraction. Build a habit of always checking the lymph node section of the final pathology report before submitting the abstraction.

3. Pre-Operative Malnutrition in Neoadjuvant Chemotherapy Patients. The combination of cancer-related cachexia and platinum-based chemotherapy toxicity leaves a large proportion of 51585 patients in a nutritionally depleted state at the time of surgery. Albumin levels at admission, documented body weight trends, and dietitian consultation notes are all clinical evidence that can support a physician query for malnutrition documentation. Severe malnutrition (E43 — MCC) is the highest-value undercoded diagnosis in this population and is genuinely present in a large proportion of cases. Never code malnutrition without physician documentation — but a well-targeted query is clinically appropriate and ethically sound.

4. Bowel-Related Complications Must Always Be Coded. Post-operative ileus, anastomotic leak, small bowel obstruction, and wound dehiscence are all reasonably foreseeable complications of 51585 given the extent of bowel manipulation. When the physician documents these conditions — not merely when they appear in nursing notes or lab values — they must be coded. K56.7 (Ileus — CC), T81.32XA (Disruption of internal operation wound — CC), and post-operative infection codes all represent CC-value diagnoses that contribute to DRG tier optimization.

5. The Stomal Education Visit Is Not a Separate Surgical Service. Pre-operative stomal site marking by a wound-ostomy-continence (WOC) nurse and post-operative ostomy appliance education are nursing services and are not separately billable surgical services by the operating physician. These should not appear on the professional surgical claim for 51585.

6. Ureteral Stent Removal Within Global Period. The ureteral stents placed at the time of conduit creation are routinely removed 7-10 days post-operatively by pulling them through the stomal opening, typically as an outpatient or bedside procedure. If performed by the operating surgeon within the 90-day global period, this is a bundled global service and is not separately billable. Educate clinic schedulers and billing staff to avoid inadvertent separate claims for stent removal during the global window.

7. Robotics and 51585. There is no dedicated robotic-assisted code for 51585. When a cystectomy, bilateral pelvic PLND, and ileal conduit are performed via a robotic-assisted or fully laparoscopic approach, the appropriate unlisted code (51999 — Unlisted Laparoscopic Procedure, Bladder) is reported, with documentation supporting comparison to 51585 as the analogous open procedure for pricing purposes. The ICD-10-PCS approach character changes to 4 (Percutaneous Endoscopic) for the robotic or laparoscopic components.

Always verify wRVU values, modifier guidelines, global period rules, and MS-DRG relative weights against the current-year CMS Physician Fee Schedule, the current-year ICD-10-CM Official Guidelines for Coding and Reporting, and applicable MAC LCD/NCD policies. HCC model assignments should be confirmed against the current CMS HCC model documentation for the applicable payment year.

Graph View

Recent Notes